These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 34112473)

  • 1. What's New in the Treatment of Urticaria and Angioedema.
    Khan DA; Kocatürk E; Bauer A; Aygören-Pürsün E
    J Allergy Clin Immunol Pract; 2021 Jun; 9(6):2170-2184. PubMed ID: 34112473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Managing Chronic Urticaria and Recurrent Angioedema Differently with Advancing Age.
    Longhurst HJ; Gonçalo M; Godse K; Ensina LF
    J Allergy Clin Immunol Pract; 2021 Jun; 9(6):2186-2194. PubMed ID: 33819638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of Chronic Spontaneous Urticaria in Routine Clinical Practice Following the EAACI/GA(2)LEN/EDF/WAO Guidelines.
    Marín-Cabañas I; Berbegal-de Gracia L; de León-Marrero F; Hispán P; Silvestre JF
    Actas Dermosifiliogr; 2017 May; 108(4):346-353. PubMed ID: 28219634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Comprehensive Approach to Urticaria: From Clinical Presentation to Modern Biological Treatments Through Pathogenesis.
    Folci M; Ramponi G; Brunetta E
    Adv Exp Med Biol; 2021; 1326():111-137. PubMed ID: 33385176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacotherapy of chronic spontaneous urticaria.
    Makris M; Maurer M; Zuberbier T
    Expert Opin Pharmacother; 2013 Dec; 14(18):2511-9. PubMed ID: 24195758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Classification and pathophysiology of angioedema].
    Buttgereit T; Maurer M
    Hautarzt; 2019 Feb; 70(2):84-91. PubMed ID: 30506093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Classification, Pathogenesis, Diagnostic Workup, and Management of Urticaria: An Update.
    Maurer M; Zuberbier T; Metz M
    Handb Exp Pharmacol; 2022; 268():117-133. PubMed ID: 34247278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What are the effects of omalizumab in refractory chronic spontaneous urticaria?
    López M; Navajas-Galimany L
    Medwave; 2015 Dec; 15 Suppl 3():e6346. PubMed ID: 26731420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of omalizumab on angioedema in H1 -antihistamine-resistant chronic spontaneous urticaria patients: results from X-ACT, a randomized controlled trial.
    Staubach P; Metz M; Chapman-Rothe N; Sieder C; Bräutigam M; Canvin J; Maurer M
    Allergy; 2016 Aug; 71(8):1135-44. PubMed ID: 27010957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic Urticaria: An Overview of Treatment and Recent Patents.
    Hon KL; Leung AKC; Ng WGG; Loo SK
    Recent Pat Inflamm Allergy Drug Discov; 2019; 13(1):27-37. PubMed ID: 30924425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biologics for the Use in Chronic Spontaneous Urticaria: When and Which.
    Maurer M; Khan DA; Elieh Ali Komi D; Kaplan AP
    J Allergy Clin Immunol Pract; 2021 Mar; 9(3):1067-1078. PubMed ID: 33685605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angioedema in the omalizumab chronic idiopathic/spontaneous urticaria pivotal studies.
    Zazzali JL; Kaplan A; Maurer M; Raimundo K; Trzaskoma B; Solari PG; Antonova E; Mendelson M; Rosén KE
    Ann Allergy Asthma Immunol; 2016 Oct; 117(4):370-377.e1. PubMed ID: 27424128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How to Treat Patients with Chronic Spontaneous Urticaria with Omalizumab: Questions and Answers.
    Türk M; Carneiro-Leão L; Kolkhir P; Bonnekoh H; Buttgereit T; Maurer M
    J Allergy Clin Immunol Pract; 2020 Jan; 8(1):113-124. PubMed ID: 31374358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical practice guideline for diagnosis and management of urticaria.
    Kulthanan K; Tuchinda P; Chularojanamontri L; Chanyachailert P; Korkij W; Chunharas A; Wananukul S; Limpongsanurak W; Benjaponpitak S; Wisuthsarewong W; Aunhachoke K; Wessagowit V; Chatchatee P; Wattanakrai P; Jirapongsananuruk O; Klaewsongkram J; Noppakun N; Vichyanond P; Suthipinittharm P; Ruxrungtham K; Singalavanija S; Ngamphaiboon J
    Asian Pac J Allergy Immunol; 2016 Sep; 34(3):190-200. PubMed ID: 27690471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent updates in urticaria.
    Giménez-Arnau AM; Manzanares N; Podder I
    Med Clin (Barc); 2023 Nov; 161(10):435-444. PubMed ID: 37537021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urticaria and angioedema.
    Kanani A; Betschel SD; Warrington R
    Allergy Asthma Clin Immunol; 2018; 14(Suppl 2):59. PubMed ID: 30263036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urticaria and Angioedema: Understanding Complex Pathomechanisms to Facilitate Patient Communication, Disease Management, and Future Treatment.
    Konstantinou GN; Riedl MA; Valent P; Podder I; Maurer M
    J Allergy Clin Immunol Pract; 2023 Jan; 11(1):94-106. PubMed ID: 36610760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urticaria and Angioedema: an Update on Classification and Pathogenesis.
    Radonjic-Hoesli S; Hofmeier KS; Micaletto S; Schmid-Grendelmeier P; Bircher A; Simon D
    Clin Rev Allergy Immunol; 2018 Feb; 54(1):88-101. PubMed ID: 28748365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angioedema With Normal Complement Studies: What Do We Know?
    Katelaris CH; Grumach AS; Bork K
    J Allergy Clin Immunol Pract; 2023 Aug; 11(8):2309-2314. PubMed ID: 37343921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biologics in Chronic Urticaria.
    Bulkhi A; Cooke AJ; Casale TB
    Immunol Allergy Clin North Am; 2017 Feb; 37(1):95-112. PubMed ID: 27886913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.